Pharmaceutical Technology

JULY 20, 2022

It was established in the study that various BET proteins play distinct roles in the infection cycle and could lead to the development of therapies that act on particular BET proteins or their parts in the future. But certain elements of these drugs could be adapted for future drug development.”.

Protein 278

Protein Scientist Gene DNA 278

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 15, 2024

a global leader in analytical and clinical laboratory technologies, announced that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. Agilent Technologies Inc., The […]

Production 188

Production Development Scientist Drugs 188

Pharmaceutical Technology

DECEMBER 15, 2022

Eisai has entered a comprehensive research partnership agreement with Washington University School of Medicine in St Louis, US, to develop potential new therapies for neurodegenerative ailments. Under the deal, the parties intend to develop treatments for diseases including Alzheimer’s and Parkinson’s.

Development 246

Development Medicine Sales Scientist 246

Bio Pharma Dive

DECEMBER 20, 2023

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research 356

Research Doctor Doctors Scientist 356

Bio Pharma Dive

NOVEMBER 16, 2021

Sandrock championed the controversial Alzheimer's drug, and was integral to the development of several other of Biogen's most important medicines during his 24 years at the biotech.

Scientist 281

Scientist Medicine Development Drugs 281

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 8, 2024

Turning off a gene early in mouse development led researchers to end up with an accidental six-legged embryonic mammal. This strange result took the spinal cord research of developmental biologists Anastasiia Lozovska and Moisés Mallo and their colleagues at Portugal’s Gulbenkian Science Institute in a new direction.

Scientist 246

Scientist Gene Research Development 246

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 22, 2024

The Indian Council of Medical Research (ICMR) has announced a Request for Expressions of Interest (EoI) aimed at inviting researchers, academicians, and scientists to participate in the formulation of evidence-based guidelines for the empirical use of antibiotics in the management of sepsis, dental infections, and vaginal discharge.

Research 243

Research Development Scientist Clinical Trials 243

Pharmaceutical Technology

OCTOBER 25, 2022

BioMed X has entered a research partnership with Sanofi to leverage artificial intelligence (AI) for drug development. The partnership intends to address a 90% failure rate of new therapy candidates in clinical development, which is a key bottleneck of the pharmaceutical industry.

Development 246

Development Drugs In-Vivo Engineer 246

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 1, 2023

Developed by researchers at Harvard University in the US, the microparticle luggage could replace existing therapies, taking advantage of the tendency for errant myeloid immune […]

Scientist 246

Scientist Development Drugs Research 246

Bio Pharma Dive

DECEMBER 12, 2023

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genome 330

Genome Genomics DNA Genetics 330

Medical Xpress

NOVEMBER 22, 2024

LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.

Development 133

Development Scientist Protein Research 133

Pharmaceutical Technology

MAY 28, 2024

Scientists of QUT have secured A$4m ($2.65m) grant from the US DoD for developing new treatments for Parkinson's disease.

Scientist 246

Scientist Development 246

Bio Pharma Dive

AUGUST 11, 2020

The shot, developed by the state-backed Gamaleya Research Institute, hasn't yet been tested in the large, placebo-controlled tests scientists emphasize are needed to prove a vaccine is protective.

Vaccine 280

Vaccine Vaccination Scientist Development 280

Medical Xpress

FEBRUARY 14, 2023

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have removed a major roadblock to better understanding of mpox (formerly, monkeypox).

Scientist 98

Scientist Development Allergies Genetics 98

Pharma Times

JULY 19, 2024

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia

Scientist 153

Scientist Development 153

Bio Pharma Dive

SEPTEMBER 20, 2023

Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.

Drugs 271

Drugs Protein Scientist Development 271

Bio Pharma Dive

FEBRUARY 24, 2021

The biotech has delivered a newly developed booster shot to NIH scientists, and will test several other approaches to address emerging virus strains.

Production 264

Production Scientist Vaccination Vaccine 264

Pharma Times

FEBRUARY 12, 2024

The chip removes cells, which could become tumours, before they are implanted in a patient

Scientist 150

Scientist Development Research 150

Pharma Times

AUGUST 9, 2024

In the UK, there are an estimated 11 million people living with a neurological condition

Scientist 146

Scientist Development Research 146

Medical Xpress

APRIL 19, 2023

Scientists at Trinity College Dublin today announced a significant development toward a new therapeutic treatment of glaucoma.

Gene Therapy 131

Gene Therapy Development Gene Scientist 131

Worldwide Clinical Trials

OCTOBER 14, 2024

Given the complexity and widespread impact of autoimmune and bone health conditions, developing new therapies is essential. This shift in therapeutic strategies brings hope to millions of patients, but it also results in challenges in developing therapies that work across different populations.

Research 147

Research Clinical Trials Clinical Trials Immune Response 147

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 1, 2024

Scientists have developed a vaccine against a notorious drug-resistant superbug, targeting molecules on its surface that are also found on other bacteria and fungi.

Vaccine 244

Vaccine Vaccination Bacteria Drugs 244

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 18, 2023

A type of bacteria commonly found in human oral and gut flora could play a major role in the development of endometriosis, scientists have discovered – potentially giving us crucial insight into the development of the painful condition, and opening up new ways to treat it.

Bacteria 246

Bacteria Scientist Development Clinical Trials 246

Camargo

OCTOBER 14, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Continued development of the use of complex innovative trial designs. Continue development of the use of Real-World Evidence. Ryan Key, PhD.

Development 189

Development Packaging Packaging Generic Drugs 189

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 14, 2022

The Department of Biotechnology (DBT) is extending support to the institutions and scientists to set up Centres of Excellence in the country for nano-vaccines and nano-adjuvants, to treat cancer and other diseases.The Department has invited Letters of Intent (LoIs) for ‘Setting up of CoE in Nano-Vaccines & Nano-Adjuvants’ for a period of five years (..)

Vaccine 189

Vaccine Vaccination Development Scientist 189

Worldwide Clinical Trials

OCTOBER 14, 2024

Given the complexity and widespread impact of autoimmune and bone health conditions, developing new therapies is essential. This shift in therapeutic strategies brings hope to millions of patients, but it also results in challenges in developing therapies that work across different populations.

Research 130

Research Clinical Trials Clinical Trials Immune Response 130

Bio Pharma Dive

JULY 17, 2023

With this highly marketable dosage form, scientists can effectively formulate poorly soluble drugs and supplements, while reducing development time and costs.

Development 130

Development Drugs Scientist Marketing 130

Camargo

NOVEMBER 15, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. While not fatal to the application, this development is certainly a setback for the sponsor, primarily in terms of a delay in approval.

Development 187

Development Manufacturing Production Packaging 187

Medical Xpress

DECEMBER 12, 2022

A drug developed by Salk Institute researchers acts like a master reset switch in the intestines. The compound, called FexD, has previously been found to lower cholesterol, burn fat, and ward off colorectal cancer in mice.

Development 107

Development Scientist Drugs Research 107

Camargo

OCTOBER 14, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The FDA has also recently launched the Software Pre-Certification Pilot Program to provide an efficient regulatory framework for developers of SaMD products.

Development 196

Development Insulin Drug Delivery Production 196

STAT News

OCTOBER 5, 2022

Barry Sharpless of Scripps Research won the Nobel Prize in chemistry on Wednesday “for the development of click chemistry and bioorthogonal chemistry,” methods that have been applied in drug development and studying disease. Carolyn Bertozzi of Stanford University, Morten Meldal of the University of Copenhagen, and K.

Development 111

Development Scientist Research Drugs 111

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 10, 2023

Now, scientists have developed an AI application that promises to warn us about dangerous variants in future pandemics. The global COVID-19 pandemic has shown us just how devastating these outbreaks can be – and it could have been much worse.

Scientist 246

Scientist Development Clinical Trials Clinical Trials 246

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 8, 2023

The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year.

Vaccine 246

Vaccine Vaccination Scientist Trials 246

BioPharma Reporter

AUGUST 21, 2024

A team of scientists from the universities of Glasgow and Tel Aviv has developed a groundbreaking method to transform the brain parasite Toxoplasma gondii into a potential vehicle for delivering therapeutic treatments directly to brain cells.

Drug Delivery Systems 97

Drug Delivery Systems Drug Delivery Scientist Engineer 97

XTalks

FEBRUARY 15, 2024

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. They serve as inspiration for future generations of scientists from all backgrounds.

Life Science 115

Life Science Scientist Research Protein 115

Pharma Times

FEBRUARY 17, 2025

New test aims to revolutionise prostate cancer screening

Scientist 107

Scientist Development 107

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2023

Scientists have developed a new tool for determining the age of eye cells without sampling regenerative tissue, which could make treatments for eye disease more personalized and better targeted. The team, led by researchers from Stanford University, adapted a technique used for analyzing eye fluid.

Protein 245

Protein Scientist Research Development 245